4-phenylenediamine has been researched along with Glaucoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abrà moff, MD; Anderson, MG; Christopher, M; Fingert, JH; Hedberg-Buenz, A; Miller, K; Scheetz, TE; Tandon, A; Zarei, K | 1 |
| Fu, CT; Sretavan, D | 1 |
2 other study(ies) available for 4-phenylenediamine and Glaucoma
| Article | Year |
|---|---|
Automated Axon Counting in Rodent Optic Nerve Sections with AxonJ.
Topics: Algorithms; Animals; Axons; Cell Count; Disease Models, Animal; Glaucoma; Humans; Mice; Optic Nerve; Phenylenediamines; Staining and Labeling | 2016 |
Involvement of EphB/Ephrin-B signaling in axonal survival in mouse experimental glaucoma.
Topics: Animals; Axons; Cell Survival; Coloring Agents; Disease Models, Animal; Ephrin-B2; Ephrin-B3; Glaucoma; Intraocular Pressure; Mice; Mice, Knockout; Microscopy, Confocal; Nerve Degeneration; Ocular Hypertension; Optic Nerve Diseases; Organ Culture Techniques; Phenylenediamines; Recombinant Fusion Proteins; Retinal Ganglion Cells; Signal Transduction; Up-Regulation | 2012 |